Molecular property prediction using pretrained-BERT and Bayesian active learning: a data-efficient approach to drug design
@BMCBiology
1. This study integrates pretrained BERT (MolBERT) with Bayesian active learning (AL) to significantly improve drug discovery by efficiently predicting molecular properties with minimal labeled data. This method enhances data efficiency and accelerates drug design processes.
2. The integration of BERT, pretrained on 1.26 million compounds, allows the model to leverage rich molecular representations that enable better uncertainty estimation, a key factor for active learning in drug discovery. This separates representation learning from uncertainty estimation, optimizing both.
3. Using Bayesian active learning, the study identifies the most informative compounds for labeling, improving model performance while reducing the number of iterations needed. In comparison to conventional AL, the proposed method achieves the same results with 50% fewer iterations.
4. The experiments, including toxic compound prediction on the Tox21 and ClinTox datasets, demonstrate that the BERT-based approach outperforms traditional methods, with better model calibration and faster convergence in sample selection, particularly in toxicology.
5. The study also compares the performance of various acquisition functions, including Expected Predictive Information Gain (EPIG) and Bayesian Active Learning by Disagreement (BALD), showing that EPIG consistently provides more stable and reliable results with the BERT representations.
6. Visualizations such as UMAP and PCA illustrate the superior ability of BERT representations to create a more structured embedding space, facilitating faster and more accurate identification of useful molecular features in the active learning process.
7. One key takeaway is that using high-quality molecular representations, like those generated by MolBERT, drastically enhances uncertainty estimation, allowing for more reliable selection of compounds even when starting with limited data.
8. This work paves the way for more efficient and scalable drug discovery workflows, particularly in early-stage compound prioritization and toxicity prediction, making it a valuable tool for pharmaceutical applications.
💻Code:
github.com/Arslan-Masood/Act…
📜Paper:
jcheminf.biomedcentral.com/a…
#DrugDiscovery #AIinBiology #MachineLearning #ActiveLearning #Bioinformatics #DrugDesign #MolecularPrediction #BayesianLearning #BERT #Chemoinformatics